-
公开(公告)号:US10233231B2
公开(公告)日:2019-03-19
申请号:US15203035
申请日:2016-07-06
发明人: Dhere Rajeev Mhalasakant , Pisal Sambhaji Shankar , Peddi Reddy Srinivas Reddy , Singh Digamber Chahar , Pardeep Gupta
IPC分类号: C07K16/00 , C07K16/10 , A61K39/395 , C07K1/22
摘要: This invention provides an improved process for manufacturing a Rabies monoclonal antibody (HuMab 17C7) that results in low osmolality, minimum secondary metabolites like ammonia and lactate, enhanced cell growth and productivity, minimum aggregation or degradation of monoclonal antibody during purification, thereby improving potency of monoclonal antibody (HuMab 17C7) as compared to human rabies immunoglobulin (hRIG).